kuvura kanseri nshya y'ibihaha

Iterambere rya vuba muri kuvura kanseri nshya y'ibihaha Gutanga uburyo bwiza bwo kubaho nubwiza bwubuzima kubarwayi. Ibi birimo amashanyarazi, Imbura, hamwe nubuhanga budasanzwe. Gusobanukirwa aya mahitamo birashobora guha imbaraga abarwayi nimiryango yabo kugirango bafate ibyemezo byuzuye hamwe nabatanga ubuzima bwabo. Iyi ngingo iratanga incamake yimiterere yanyuma no kuvura no kuvura kanseri y'ibihaha kandi hakenewe kanseri nshya yo kwivuza ikomeje kuba ikibazo cyubuzima bwisi kwisi yose. Ni ngombwa kumva ubwoko butandukanye bwa kanseri y'ibihaha kandi ibintu bigira uruhare mu iterambere ryayo. Imiti gakondo nka chemiotherapie na chemiotherap hamwe nubuvuzi bwimizigo bifite aho bigarukira, bishimangira ko bakeneye byihutirwa kuvura kanseri nshya y'ibihaha Ingamba.types y'ibihaha kanseri Ubwoko bubiri bw'ingenzi ni: Kanseri idafite kanseri nto (NSCLC): Ubu ni ubwoko bukunze kugaragara, ibaruramari bagera kuri 80-85% bya kanseri y'ibihaha. Subtypes harimo adencarcinoma, karcinoma yaka, hamwe na karcinoma nini. Kanseri ntoya ya selile (SCLC): Ubu bwoko ntibusanzwe kandi bukunda gukura no gukwirakwira vuba kuruta NSCLC.breakthroughs mubihe byibasiwe mu kuvura ibihuha ni a kuvura kanseri nshya y'ibihaha byibanda kuri molekile zihariye bagize uruhare mugutezimbere kwa Kanseri no kubaho. Bitandukanye na chimiotherapie, ibitero byose bigabanya ingirabuzimafatizo, intego zigenewe intego zigamije guhitamo kwica selile za kanseri mugihe ukinga ubuzima bwiza. Ibi akenshi biganisha ku ngaruka nkeya.com zagenewe TheRapies hamwe nibitekerezo byabo bigamije ubuvuzi bugenewe gukoreshwa muburyo bumwe bwa NSCLC. Izi mvugo zikunze kwibasira ihinduka ry'inguriro nka EGFR, ALK, ROS1, Craf, yahuye, na NTRK. Intego Urugero rwibiyobyabwenge byihariye NSCLC Egfr osimertib (TagSoso) NSCLC hamwe na EGFR (Alecensa) NSCLC hamwe na NSCLC hamwe na ROZLC hamwe na ROS1 rearrangemes isoko: Sosiyete y'AbanyamerikaUruhare rwa Biomarker rutangira kugeza rutangira kuvura rugamije, kwipimisha ibinyabuzima ni ngombwa. Ikigeragezo kirimo gusesengura icyitegererezo cyumurwayi kugirango umenye umwihariko wa ruswa cyangwa idasanzwe. Ibisubizo by'icyiciro cya biomarker bufasha abaganga kumenya niba umurwayi ashobora kungukirwa n'ubuvuzi runaka. The Shandong Baofa Kanseri Ikigo cyubushakashatsi ashimangira akamaro ko gusuzuma neza kugirango uvurwe neza kuvura kanseri nshya y'ibihaha. Ubu buryo bukora mugukangurira sisitemu yumubiri wumurwayi kugirango tumenye no gutera kanseri ya kanseri. Impumuro nziza, nka chequers, guhagarika poroteyine irinda imikorere yumubiri kubaterankunga.types ibiyobyabwenge bya imyumbati kubiyobyabwenge byahagaritswe bikoreshwa mubihaha birimo: Pd-1 abaramo: Pembezimab (Keytruda), NIVOLUMAB (OPDIVO) Pd-l1 abarashi: Atezolizumab (Tecentriq), Durvalumab (IMFINZI) CTLA-4 Abagizi ba nabi: Ipilimab (yturgoy) (akenshi ikoreshwa hamwe na pd-1 inhinator) ninde mukandida wa kanseri ya imfururate? Icyemezo cya kanseri ya PD-L1 PD-L1 ni poroteyine ishobora gufasha kanseri ikura sisitemu yumubiri. Abarwayi bafite imvugo ndende PD-L1 birashoboka cyane ko basubiza imbumbe. Abaganga b'abaganga bazasuzuma bitonze buri murwayi kugirango bamenye niba imyumbati ikwiye.ubuhanga bwo kubaga muri kanseri y'ibihaha bikomeza kuba igice cy'ingenzi cya kuvura kanseri nshya y'ibihaha, cyane cyane kuri ontes-status. Iterambere mu buryo bwo kubaga bwateje inzira nkeya ziteye kandi zitezeho ingaruka zo kubaga amashusho, eka ko basabye kubaga amashusho, emera kubaga bakuraho ibibyimba binyuze mu mato. Ubu buhanga butanga ibyiza byinshi kubagwa gakondo, harimo ububabare buke, ibitaro bigufi byibitaro bya radio. SBRT SBRT itanga umusaruro mwinshi wimirasire mugihe ugabanya ibintu bikikije ibiganiro byiza .Ibibazo byo kuvura neza kuvura kanseri nshya y'ibihaha bikubiyemo guhuza amashanyarazi atandukanye. Kurugero, abarwayi barashobora kwakira chimitherapie bakurikirwa no kubaga, cyangwa kwivuza bigamije guhuza na impfuya. Ihuriro ryihariye ryubwitonzi rizaterwa nibibazo byumurwayi kugiti cye.Hingirakamaro mubigeragezo byamavukire bigira uruhare runini mugutezimbere kuvura kanseri nshya y'ibihaha ingamba. Ibi bigeragezo bisuzuma umutekano nuburyo bukora imiti mishya no kwivuza. Abarwayi bitabira ibigeragezo by'amavuriro bashobora kuba bafite uburyo bwo guca ahagaragara ubuvuzi butaraboneka cyane. Tekereza kuganira ku mahitamo yubuvuzi hamwe na oncologue yawe. Amakuru yerekeye inzira zubuvuzi zijyanye nubushakashatsi bwa kanseri urashobora kubisanga kuri Shandong Baofa Kanseri Ikigo cyubushakashatsi Urubuga.living hamwe na kanseri y'ibihaha: Gushyigikira no gutangaza kanseri y'ibihaha birashobora kuba byinshi. Ni ngombwa gushaka inkunga abigize umwuga w'ubuvuzi, umuryango, inshuti, n'amatsinda atera inkunga. Amashyirahamwe menshi atanga Umutungo na serivisi kugirango afashe abarwayi nimiryango yabo guhangana ningorane zo kubana na kanseri y'ibihaha.concouscipt. kuvura kanseri nshya y'ibihaha mu myaka yashize. Abakozi bagenewe, Imburanga, hamwe nubuhanga budasanzwe bwo kubaga butanga ibyiringiro bishya kubarwayi bafite kanseri y'ibihaha. Mugukomeza kumenyeshwa iterambere rigezweho kandi nkorana cyane nitsinda ryabo ryubuzima, abarwayi barashobora gufata ibyemezo byuzuye kandi banoza amahirwe yo kubaho no kumererwa ubuzima.